Audit 335093

FY End
2024-06-30
Total Expended
$60.55M
Findings
0
Programs
39
Year: 2024 Accepted: 2024-12-30

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.498 Provider Relief Fund and American Rescue Plan (arp) Rural Distribution $45.23M Yes 0
93.185 Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects $1.67M Yes 0
93.461 Hrsa Covid-19 Claims Reimbursement for the Uninsured Program and the Covid-19 Coverage Assistance Fund $1.51M - 0
93.558 Temporary Assistance for Needy Families $999,348 - 0
93.310 Trans-Nih Research Support $538,973 Yes 0
17.278 Wioa Dislocated Worker Formula Grants $444,000 - 0
93.590 Community-Based Child Abuse Prevention Grants $376,000 - 0
93.262 Occupational Safety and Health Program $357,623 Yes 0
93.172 Human Genome Research $305,408 Yes 0
16.575 Crime Victim Assistance $253,241 - 0
93.253 Poison Control Stabilization and Enhancement Grants $230,491 - 0
17.285 Registered Apprenticeship $222,667 - 0
12.420 Military Medical Research and Development $214,536 Yes 0
93.433 Acl National Institute on Disability, Independent Living, and Rehabilitation Research $179,118 Yes 0
93.350 National Center for Advancing Translational Sciences $120,564 Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $119,940 Yes 0
93.155 Rural Health Research Centers $93,581 - 0
93.242 Mental Health Research Grants $49,034 Yes 0
93.788 Opioid Str $40,000 Yes 0
93.307 Minority Health and Health Disparities Research $39,169 Yes 0
93.393 Cancer Cause and Prevention Research $19,332 Yes 0
93.912 Rural Health Care Services Outreach, Rural Health Network Development and Small Health Care Provider Quality Improvement $17,088 - 0
93.396 Cancer Biology Research $17,026 Yes 0
93.866 Aging Research $15,155 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $12,674 Yes 0
12.001 Minority Business Development Management and Technical Assistance $10,920 Yes 0
93.838 Lung Diseases Research $9,800 Yes 0
93.394 Cancer Detection and Diagnosis Research $7,363 Yes 0
93.395 Cancer Treatment Research $5,450 Yes 0
93.837 Cardiovascular Diseases Research $5,063 Yes 0
93.855 Allergy and Infectious Diseases Research $4,760 Yes 0
93.840 Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders $3,200 Yes 0
93.279 Drug Abuse and Addiction Research Programs $1,554 Yes 0
93.173 Research Related to Deafness and Communication Disorders $1,538 Yes 0
10.558 Child and Adult Care Food Program $333 - 0
97.044 Assistance to Firefighters Grant $-76 - 0
93.470 Alzheimer�s Disease Program Initiative (adpi) $-1,846 Yes 0
93.421 Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nation�s Health $-3,764 Yes 0
12.910 Research and Technology Development $-103,699 Yes 0

Contacts

Name Title Type
HCKZW5VKNU93 Amy Martin Auditee
2148202677 Patrick Church Auditor
No contacts on file

Notes to SEFA

Title: Basis of Presentation Accounting Policies: Significant Accounting Policies, Provider Relief Fund De Minimis Rate Used: N Rate Explanation: BSWH uses its predetermined/negotiated indirect cost rate rather than the 10% de minimis indirect cost rate described in the Uniform Guidance. The accompanying Schedule of Expenditures of Federal Awards (the “Schedule”) includes the federal grant activity of Baylor Scott & White Holdings and Its Controlled Affiliates (collectively referred to as the “System” or “BSWH”) and are presented on the accrual basis of accounting. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this Schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements of BSWH. Negative amounts represent adjustments made to amounts reported in the prior year in the normal course of business. BSWH uses its predetermined/negotiated indirect cost rate rather than the 10% de minimis indirect cost rate described in the Uniform Guidance. The Identifier Number included in the Schedule represents the pass through entity identifying number or other identifier.
Title: Provider Relief Fund Accounting Policies: Significant Accounting Policies, Provider Relief Fund De Minimis Rate Used: N Rate Explanation: BSWH uses its predetermined/negotiated indirect cost rate rather than the 10% de minimis indirect cost rate described in the Uniform Guidance. The Schedule includes grant activity related to the Department of Health and Human Services ("HHS") Coronavirus Aid Relief and Economic Security (CARES) Act Assistance Listing Number 93.498. As required based on guidance in the 2024 OMB Compliance Supplement, the Schedule includes period 6 funds received between July 1, 2022 and December 31, 2022 and expended by December 31, 2023 as reported to the Health Resources and Services Administration ("HRSA") via the Provider Relief Fund Reporting Portal.